Impact of resection status on pattern of failure and survival after pancreaticoduodenectomy for pancreatic adenocarcinoma.
about
A systematic review of the role of periadventitial dissection of the superior mesenteric artery in affecting margin status after pancreatoduodenectomy for pancreatic adenocarcinomaTotal pancreatectomy for pancreatic ductal adenocarcinoma: review of the National Cancer Data BasePerioperative Therapy for Surgically Resectable Pancreatic AdenocarcinomaManagement of borderline and locally advanced pancreatic cancer: where do we stand?Neoadjuvant therapy for pancreas cancer: past lessons and future therapiesRe-evaluation of classical prognostic factors in resectable ductal adenocarcinoma of the pancreasUpdate on the management of pancreatic cancer: surgery is not enoughEvaluation of uric acid as a prognostic blood-based marker in a large cohort of pancreatic cancer patientsImaging of targeted lipid microbubbles to detect cancer cells using third harmonic generation microscopy.Recurrence after operative management of intrahepatic cholangiocarcinomaPancreas-protocol imaging at a high-volume center leads to improved preoperative staging of pancreatic ductal adenocarcinoma.Preoperative capecitabine and concurrent radiation for borderline resectable pancreatic cancer.Phase-change nanoparticles using highly volatile perfluorocarbons: toward a platform for extravascular ultrasound imagingRadiographic tumor-vein interface as a predictor of intraoperative, pathologic, and oncologic outcomes in resectable and borderline resectable pancreatic cancer.Neoadjuvant therapy may lead to successful surgical resection and improved survival in patients with borderline resectable pancreatic cancer.Escalating computed tomography angiogram (CTA) grade predicts unresectability and margin status for pancreaticobiliary neoplasmsDiagnosis and management of pancreatic cancer.Predictors of survival in periampullary cancers following pancreaticoduodenectomy.Adjuvant chemoradiation for pancreatic cancer: what does the evidence tell us?Multimodality therapy offers a chance for cure in patients with pancreatic adenocarcinoma deemed unresectable at first operative explorationIdentifying the neck margin status of ductal adenocarcinoma in the pancreatic head by multiphoton microscopyA neoadjuvant strategy for pancreatic adenocarcinoma increases the likelihood of receiving all components of care: lessons from a single-institution database.Serum CA 19-9 as a marker of resectability and survival in patients with potentially resectable pancreatic cancer treated with neoadjuvant chemoradiationPancreatic cancer-improved care achievableImpact of tumor grade on prognosis in pancreatic cancer: should we include grade in AJCC staging?Pancreatic adenocarcinomaAdjuvant chemoradiation therapy for pancreatic adenocarcinoma: who really benefits?The role of surgery for pancreatic cancer: a 12-year review of patient outcome.Management of pancreatic cancer: current status and future directionsAdvances in diagnosis, treatment and palliation of pancreatic carcinoma: 1990-2010.Neoadjuvant FOLFIRINOX for borderline resectable pancreas cancer: a new treatment paradigm?Pathology handling of pancreatoduodenectomy specimens: Approaches and controversies.Pancreaticoduodenectomy with vascular reconstruction for adenocarcinoma of the pancreas with borderline resectability.Long-term survival after multidisciplinary management of resected pancreatic adenocarcinoma.Surgical management of adenocarcinoma of the pancreatic uncinate process in a cancer hospital in egypt.Screening for pancreatic cancer: current evidence and future directions.Standard and extended lymphadenectomy for adenocarcinoma of the pancreatic head: a meta-analysis and systematic review.External validation of the derived neutrophil to lymphocyte ratio as a prognostic marker on a large cohort of pancreatic cancer patients.Laparoscopic pancreaticoduodenectomy via a reverse-''V'' approach with four ports: initial experience and perioperative outcomes.Intraoperative assessment of pancreatic neck margin at the time of pancreaticoduodenectomy increases likelihood of margin-negative resection in patients with pancreatic cancer
P2860
Q26748880-0516DFAF-9590-4CF1-918D-0119529FDEE4Q26771577-ED285C14-E5B4-445A-A3F3-197930503637Q26801411-7E0C909A-8C4B-41D1-81DF-D743E5BF685BQ26825414-CB53A5DA-1308-43D0-B5DB-2A7C324CF21EQ27004292-919B0486-BEDD-41EF-BDEB-03BBC8D6578DQ28075892-CE085152-6F60-4F4E-A11B-4079D8509310Q28087060-3814235C-59D6-427D-9E4F-4ED28D600465Q28542043-E393AF75-0181-4FDF-BAA8-63A4FD256661Q30378401-40E8532F-A8FE-4B3F-BAF1-37C111D2E49CQ30412886-751CB0E0-5891-4866-BDCE-00762774BE62Q30430414-923E811F-25D6-4553-BD5F-47AFC70B2073Q30452636-C30BA7D4-C362-4B66-B851-5CD53A289A1DQ30458493-01E1748D-F162-4FC3-A290-CA66E8345078Q33590511-DC9808C7-1B65-46B8-8F1C-FC215503ED84Q33622827-2DF9AE49-F5A8-40D7-B1DE-73ECBC622176Q33679661-8B72CE24-FFBD-401E-B638-BD9B1B23803AQ33759924-A676D0D1-6CC2-4705-AF3F-F1223F832865Q33819380-40625ACD-A7C4-4E44-A728-31D854A8860AQ33820788-DADB8927-8247-4C31-8A06-7BD456FCD5D2Q33860986-FF12E17F-6A71-4010-B18D-3EE779E7EC8CQ33870913-D4AE45E2-C44C-4698-839B-2DD3B653CA48Q33928176-E9701F91-7E84-4225-9777-B13CF583A972Q33928253-5A628C02-2140-4A46-9BAE-EDA17525F865Q34036659-9C305D3B-C0BA-4619-9407-06D0E5164422Q34075815-6CB6EDD5-52DF-4643-BAD9-076269E9E639Q34140498-07DE9747-1EA6-47FF-9FDD-B37ADC2CA1E3Q34205488-8BD6FFCC-27B3-415C-B2EC-87CA86889E93Q34357302-64B3E3C0-319D-4889-A27A-C3D42CF8FB1FQ34409883-353C8293-5A5F-469C-81E0-E707256CF211Q34635042-96298FE4-C74F-48C3-869D-342B620ADED5Q34659974-EA0FECC1-6C25-4BF3-8474-CC3E31DE01CBQ34664747-AAD70E78-99A5-4D7D-807C-B376E28F2B6BQ34696705-ED047A68-5EF8-4363-B2DB-2733A61EE997Q34732306-4C203960-2C73-4986-9A10-24B6C7073080Q34973733-922382F0-A2A2-4BF4-B75B-175DEDEE1A4EQ35014007-55453FB5-043F-4BC2-AA4A-98B6CF772DB3Q35027210-F4FB8899-D24D-419E-8A17-0A0B9E658F03Q35040836-0EDD03B4-E4A1-4150-A829-133872DD7962Q35045785-32C2C85C-D4D4-4CBF-A9DB-9AB87F3EFA86Q35160584-93BEB12F-71A3-46C8-AF74-3C7B31DE8A55
P2860
Impact of resection status on pattern of failure and survival after pancreaticoduodenectomy for pancreatic adenocarcinoma.
description
2007 nî lūn-bûn
@nan
2007年の論文
@ja
2007年学术文章
@wuu
2007年学术文章
@zh
2007年学术文章
@zh-cn
2007年学术文章
@zh-hans
2007年学术文章
@zh-my
2007年学术文章
@zh-sg
2007年學術文章
@yue
2007年學術文章
@zh-hant
name
Impact of resection status on ...... for pancreatic adenocarcinoma.
@en
Impact of resection status on ...... for pancreatic adenocarcinoma.
@nl
type
label
Impact of resection status on ...... for pancreatic adenocarcinoma.
@en
Impact of resection status on ...... for pancreatic adenocarcinoma.
@nl
prefLabel
Impact of resection status on ...... for pancreatic adenocarcinoma.
@en
Impact of resection status on ...... for pancreatic adenocarcinoma.
@nl
P2093
P2860
P1433
P1476
Impact of resection status on ...... for pancreatic adenocarcinoma.
@en
P2093
Chandrajit P Raut
Charlotte C Sun
Christopher H Crane
Douglas B Evans
Eddie K Abdalla
Huamin Wang
Jean-Nicolas Vauthey
Jeffrey E Lee
Jennifer F Tseng
Peter W T Pisters
P2860
P356
10.1097/01.SLA.0000259391.84304.2B
P407
P577
2007-07-01T00:00:00Z